Modified protocols improve insulin sensitivity estimation using the minimal model
- 1 December 1987
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 253 (6) , E595-E602
- https://doi.org/10.1152/ajpendo.1987.253.6.e595
Abstract
We attempted to improve the precision of the estimation of insulin sensitivity (S1) from the minimal model technique by modifying insulin dynamics during a frequently sampled intravenous glucose tolerance test (FSIGT). Tolbutamide and somatostatin (SRIF) were used to change the insulin dynamics without directly affecting insulin sensitivity. Injection of tolbutamide (100 mg) at t = 20 min provoked an immediate secondary peak in insulin response, resulting in a greater integrated incremental insulin than the standard FSIGT. SRIF, injected at t = -1 min, delayed insulin secretion in proportion to the dose without any change in magnitude. Computer simulation was used to assess the precision of S1 estimation. Insulin dynamics from both standard and modified protocols were adjusted in magnitude, with the shape unchanged and analyzed to determine the effect of the magnitude of insulin response. Fractional standard deviation was reduced from 73% with the standard insulin profile to 23% with tolbutamide and 18% with the highest dose of SRIF. In addition, the fractional standard deviation of S1 estimates decreased exponentially with increasing magnitude of insulin response. Modified FSIGTs require a smaller insulin response than the standard protocol to achieve the same precision.This publication has 10 references indexed in Scilit:
- The Insulin Sensitivity Index in Nondiabetic Man: Correlation Between Clamp-derived and IVGTT-derived ValuesDiabetes, 1986
- Importance of Glucose Per Se to Intravenous Glucose Tolerance: Comparison of the Minimal-Model Prediction with Direct MeasurementsDiabetes, 1985
- Presentation of a New Method for Specific Measurement of in Vivo Insulin-Stimulated Glucose Disposal in Humans: Comparison of This Approach with the Insulin Clamp and Minimal Model Techniques*Journal of Clinical Endocrinology & Metabolism, 1985
- Gliclazide Therapy Is Associated with Potentiation of Postbinding Insulin Action in Obese, Non-insulin-dependent Diabetic SubjectsDiabetes, 1985
- Sulfonylureas Enhance In Vivo the Effectiveness of Insulin in Type 1 (Insulin Dependent) Diabetes MellitusHormone and Metabolic Research, 1984
- Half-Life of Somatostatin-Like Immunoreactivity in Canine Plasma*Endocrinology, 1979
- INHIBITION OF INSULIN SECRETION BY SOMATOSTATINThe Lancet, 1973
- Effect of Arginine on Glucose Turnover and Plasma Free Fatty Acids in Normal DogsDiabetes, 1973
- Effect of growth hormone on carbohydrate metabolism in normal and hypophysectomized dogs; studies with C14 glucoseAmerican Journal of Physiology-Legacy Content, 1958